-
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
Biotech Newswire
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
-
International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.
PharmaSources.com
May 27, 2022
HongKe(虹科) Technology Co., Ltd., established in 2007 (previously HongKe(宏科) founded in 1995), is headquartered in Guangzhou, the economic and cultural center of southern China.
-
Discovering Biotechnology: Top 9 Chinese Pharmaceutical Companies in 2020
Deborah Seah
November 04, 2020
China 's pharmaceutical industry garnered a total revenue of about 2.6 trillion yuan in 2019 amounting to an eight percent year-on-year growth.
-
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics
B3CNewswire
January 05, 2024
On January 4, 2024, Beijing time, Allorion Therapeutics announced that it has entered into a transfer agreement with Avenzo Therapeutics, Inc. (Avenzo) of the United States
-
Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization
B3C newswire
November 16, 2023
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the permanent Manufacturer’s Authorization for its clinical development site in Rankweil, Austria.
-
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site
PharmaSources
May 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
-
Biotech and pharma services outsourcing market to be worth over $91bn by 2028
europeanpharmaceuticalreview
April 14, 2021
A new report suggests the global biotechnology and pharmaceutical services outsourcing market will grow because of the pandemic and rising drug development costs and R&D investments.
-
Thailand BOI Okays Biotech Projects Worth 2.4 Bln Baht in Total Investment
prnasia
April 08, 2021
The Thailand Board of Investment (BOI) said it has recently approved new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, reflecting the increased interest of local and foreign ...
-
INSERM leads in patent applications, reports European Patent Office
europeanpharmaceuticalreview
March 13, 2020
According to the European Patent Office (EPO), in 2019 the number of patents filed in the pharmaceutical and biotechnology sectors rose for a third consecutive year.
-
Malaysia to host Biotechnology 2019 summit
biospectrumasia
August 21, 2019
Malaysia is emphasizing on recent areas of more optimized research techniques in Biotech and Genetic technologies